ARTICLE | Clinical News
Temsirolimus: Phase II data
May 23, 2005 7:00 AM UTC
Data from a Phase II trial in 92 post-menopausal women with locally advanced or metastatic breast cancer showed that temsirolimus plus letrozole was well tolerated and showed clinical activity. Patien...